Egyptian Hep C Problem to Benefit from Better Test | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Hepatitis C Phase 3 Trials Underway for TMC435

Back to News Homepage
Next

New Hep C Vaccine Approach Pursued by Okairos

Egyptian Hep C Problem to Benefit from Better Test

The Editors at Hepatitis Central
March 14, 2012

Print this page

Boasting the world’s highest rate of Hepatitis C, Egypt has a lot to gain from the American University in Cairo’s fast and inexpensive Hepatitis C test.

Hepatitis C test helps curb Egypt epidemic

Pete Willows | 8 March 2012

CAIRO: About 10 million hepatitis C (HCV) patients live in Egypt, giving Egypt the distinction of having the highest prevalence of hepatitis C in the world. According to a recent study published in the Proceedings of the National Academy of Science, the blood-borne pathogen infects almost 500,000 people in the country each year. According to the World Health Organization, the strong homogeneity of HCV subtypes found in Egypt (HCV4a) suggests an epidemic spread of HCV in the country.

In response to this rapidly spreading virus, an American University in Cairo (AUC) research team at the Yousef Jameel Science and Technology Research Center, led by Hassan Azzazy, professor of chemistry, has designed a novel test capable of detecting all genotypes of HCV in less than one hour, instead of days, and at one-tenth of the cost of traditional tests.

“Our test is sensitive and inexpensive, and it does not need sophisticated equipment,” explained Azzazy, adding that detecting HCV during the first six months raises the recovery rate to 90 percent. “Little is done on the national level to combat the alarming prevalence of hepatitis C in Egypt.”

Continue reading this entire article:

http://bikyamasr.com/61019/one-hour-hepatitis-c-diagnostic-test-helps-curb-egypt-epidemic/

No Comments - be the first!
Share
Share
Previous

Hepatitis C Phase 3 Trials Underway for TMC435

Back to News Homepage
Next

New Hep C Vaccine Approach Pursued by Okairos

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.